29th November, 2016
OPERON is glad to announce the launching of its new product: CT/NG/MG OligoGen.
Chlamydia trachomatis is the pathogen of the greatest prevalence in sexually transmitted infections (STIs) in the Western world. It affects humans exclusively. Despite its high prevalence, it is one of the least-diagnosed aetiologic agents, due to the high percentage of cases of asymptomatic infection. There are 18 known serotypes distributed in three biovars or pathotypes, each responsible for a different infectious process: trachoma, lymphogranuloma venereum (LGV) and Non-invasive oculogenital infection.
Neisseria gonorrhoeae (gonococcus) is the aetiological agent of gonorrhoea, one of the most common sexually transmitted diseases (STDs). The clinical manifestations of infection by NG are numerous. In the case of men, the most common complications are urethritis and epididymitis, while in women the cervical canal is the most common site of infection.
Mycoplasma genitalium is a small bacterium from the genitourinary tract that lives in the ciliated epithelial cells of the reproductive and respiratory apparatuses. M. genitalium has recently been proposed to be the causative agent of frequent urethritis in men and lower reproductive tract infections in women.
CT/NG/MG OligoGen is a test designed for the qualitative detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG) through the amplification of specific genomic regions for every pathogen and their subsequent identification by oligo-immunochromatography. The test allows the simple, economic and reliable detection of all the infections caused by CT, NG and MG.
If you are interested in our CT/LGV OligoGen kit, please visit CT/LGV OligoGen.
If you are interested in personalized solutions, please visit our Customized Services.